Ismail Amin, Esq.

Founder/Partner

Practice Areas

About Ismail

Ismail Amin is a multi-jurisdictional practitioner with substantial experience in business, securities, and biotechnology transactions and disputed matters. He has handled disputes across the globe and throughout the United States on behalf of Fortune 500 companies and mid-sized privately held companies in diverse fields such as biologics, biotechnology, banking, financial services, and securities regulation.

In the Board Room – Ismail has counseled the firm’s healthcare provider and business clients in acquiring or selling assets while maximizing return and minimizing risk. He has helped clients acquire or sell over $5 billion worth of healthcare-related assets, including hospitals. Moreover, Ismail has substantial experience in various forms of mergers and acquisitions involving both acquiring and targeting clients. Additionally, he has guided healthcare and biotech clients through various Food & Drug law and FDA regulatory issues, including filing for Pre-Market Approval and 510(k) submissions. Ismail founded the “Biotech Bulletin” and writes extensively on emerging FDA issues affecting biologics and biotechnology companies.

Ismail is also the exclusive IR Global advisor for Banking for the Nevada & California markets.

In the Courtroom and Beyond – Ismail has considerable trial and arbitration experience, having participated in over 90 trials and arbitrations across multiple jurisdictions since the inception of his legal career, and was recently admitted to the First Circuit Court of Appeals. He has successfully litigated shareholder accounting disputes, complex securities-related actions, trade-secret matters, trademark/trade-dress infringement claims, and commercial matters. He also has substantial experience before the USPTO, having litigated multiple TTAB proceedings involving trademark disputes.

In addition to trial work, Ismail has significant appellate experience. He has briefed and argued appeals before the United States Courts of Appeals for the Fifth, Sixth, and Ninth Circuits, as well as before various state appellate courts. His appellate work spans securities regulation, constitutional issues, and complex commercial disputes.

Ismail is admitted to practice law in California, Nevada, Texas, North Carolina, and New York. He attended the University of California, Irvine, where he earned a double major in International Studies and Political Science. He received his law degree from Pepperdine University, where he currently serves on the Dean’s Council. In 2019, he earned a Graduate Certificate in Genetics & Genomics from Stanford University, followed by a Master’s degree in Biotechnology, Enterprise & Entrepreneurship from Johns Hopkins University in 2022. Most recently, he completed his Master of Laws (LL.M.) in Securities & Financial Regulation at Georgetown Law Center.

Ismail proudly serves as a Board Member for Endure to Cure – a non-profit organization that brings emotional boosts to children undergoing cancer treatment and provides support to their families. He is also a global Alder member.

Outside of law, Ismail is a licensed pilot, avid marathon runner, and Muay Thai kickboxer. He is proud to have earned Abbott Labs’ 6-star medal for completing all six of the World Marathon Majors.

Education

  • University of California, Irvine
    • Double Major, International Studies and Political Science
  • Pepperdine School of Law
    • Juris Doctorate
  • Stanford University
    • Graduate Certificate in Genetics & Genomics
  • Johns Hopkins University
    • Masters – Biotechnology, Enterprise, and Entrepreneurship
  • Georgetown Law Center
    • LLM – Securities & Financial Regulation

Professional Licensure & Admissions

  • State Bar of California; United States District Court, Central District of California
  • State Bar of Nevada; United States District Court, District of Nevada
  • State Bar of Texas; United States District Court, Southern District of Texas, Western District of Texas, Northern District of Texas
  • State Bar of North Carolina
  • State Bar of New York
  • United States Court of Appeals for the Ninth Circuit
  • United States Court of Appeals for the Fifth Circuit
  • United States Court of Appeals for the Sixth Circuit
  • United States Supreme Court
  • United States Court of Appeals for the First Circuit

Committee Affiliations & Memberships

  • Clark County Bar Association
  • Dallas Bar Association
  • New York Bar Association
  • American Bar Association
  • Federal Bar Association
  • Fellows of the Texas Bar Foundation

Published Content

TALG Biotech Bulletin®

Ismail's Recent Posts

TALG Founder Ismail Amin to Run Sydney Marathon in Support of Endure to Cure

This August, Ismail Amin, Founder and Partner at TALG, will participate in the Sydney Marathon - not just as a personal challenge, but as an opportunity to support a cause that matters deeply to him and the firm: Endure to Cure (E2C), a nonprofit organization that helps families of children facing cancer and other serious illnesses.

Towards Trustworthy AI: Building Resilience Through Policy and Compliance

Responsible adoption of AI in the US requires businesses to develop written policies governing AI usage, carefully assess platform providers, and maintain internal oversight. Regular audits and the formation of cross-functional committees are essential to ensure compliance and ethical use across departments.

Navigating AI in Business, Biotech, and Beyond

Artificial intelligence isn’t just a buzzword anymore - it’s a driving force reshaping industries across the globe. From biotechnology to banking, AI is accelerating innovation and creating both opportunities and challenges. In a recent podcast appearance, TALG’s founder and CEO, Ismail Amin, shared his insights on how AI is impacting mid-sized businesses, regulated industries, and the legal profession.

Recursive Artificial Intelligence: Can the Law Keep Up?

While Artificial Intelligence (AI) has emerged as groundbreaking and significantly impacting various sectors and enhancing quality of life, the chasm between technological advancements and the law is growing by the nanosecond.